BHSC Share Price Performance

BHSC Community Fair Values

View all narratives

Recent BHSC News & Updates

No updates

BioHarvest Sciences Inc. Key Details

Last Reported Earnings

Sep 30, 2024

Next Reporting Earnings

n/a

Earnings per share (EPS): -0.99
Gross Margin: 54.00%
Net Profit Margin: -76.65%
Debt/Equity Ratio: 28.8%

View full report ›

BioHarvest Sciences Inc. Competitors

About BHSC

Founded: n/a
Employees: n/a
CEO: Ilan Sobel
WebsiteView website: www.bioharvest.com

BioHarvest Sciences Inc. operates as a biotechnology company. The company operates through Nutraceuticals and Pharmaceuticals segments. It develops botanical synthesis platform technology to grow the ingredients in any plant enzymes or cells. The company is leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions in nutraceuticals and pharmaceuticals verticals. It also operates as a contract development and manufacturing operation services. In addition, the company offers wellness products. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red grapes. The company operates in Israel and the United States. BioHarvest Sciences Inc. is based in Vancouver, Canada.

Canadian Market Performance

0.6%

19.7%

19.3%

8.5%

In the last week, the market has stayed flat, however the Communication Services sector stood out, gaining 4.6%. As for the longer term, the market has risen 19% in the past 12 months. Earnings are forecast to grow by 12% annually. Market details ›

BioHarvest Sciences Stock Price

BHSC Share Price Performance

BHSC Community Fair Values

Recent BHSC News & Updates

BioHarvest Sciences Inc. Key Details

BioHarvest Sciences Inc. Competitors

Irwin Naturals

Promino Nutritional Sciences

Patriot Resources

Moss Genomics

Hempalta

Biosenta

Doseology Sciences

NeutriSci International

🎢 From Panic to Peak: Q2’s Wild Ride and What’s Next

🏛️ The Winners and Losers From The Stablecoin GENIUS Act